Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
47,322,813
-
Shares change
-
+10,868,479
-
Total reported value, excl. options
-
$584,436,985
-
Value change
-
+$135,063,720
-
Put/Call ratio
-
16%
-
Number of buys
-
52
-
Number of sells
-
-39
-
Price
-
$12.35
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q3 2023
114 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q3 2023.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,322,813 shares
of 68,958,635 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include BVF INC/IL (9,135,893 shares), Paradigm Biocapital Advisors LP (7,803,600 shares), Cormorant Asset Management, LP (4,504,764 shares), Logos Global Management LP (3,743,875 shares), BlackRock Inc. (2,242,889 shares), Deep Track Capital, LP (1,930,894 shares), Vivo Capital, LLC (1,873,704 shares), MPM BIOIMPACT LLC (1,857,681 shares), VANGUARD GROUP INC (1,710,307 shares), and DIMENSIONAL FUND ADVISORS LP (1,694,000 shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.